SUBJECTS : Public Health | Clinical Trials | Health Policy | Health Inequalities | Non-communicable Diseases | Europ
The Lancet Regional Health. Europe: 2024, vol: 37, issue:
- 1)- Petra Sager, Astrid Kaiser, Sara Schumann, Beate Ludescher, Michael Niedermaier, Ivo Schmidt, Katharina Och, Christiane Dings, Thorsten Lehr, Wolfgang Brysch. Efficacy and safety of MP1032 plus standard-of-care compared to standard-of-care in hospitalised patients with COVID-19: a multicentre, randomised double-blind, placebo-controlled phase 2a trial. The Lancet regional health. Europe. 2024, 37: 100810
Cited : 0Read More
